KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Assets Average (2016 - 2025)

Historic Assets Average for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to $11.2 billion.

  • Jazz Pharmaceuticals' Assets Average fell 557.62% to $11.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 billion, marking a year-over-year decrease of 557.62%. This contributed to the annual value of $11.7 billion for FY2024, which is 529.5% up from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Assets Average is $11.2 billion, which was down 557.62% from $11.2 billion recorded in Q2 2025.
  • Jazz Pharmaceuticals' 5-year Assets Average high stood at $12.8 billion for Q3 2021, and its period low was $6.6 billion during Q1 2021.
  • Over the past 5 years, Jazz Pharmaceuticals' median Assets Average value was $11.3 billion (recorded in 2023), while the average stood at $11.2 billion.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 10788.31% in 2021, then plummeted by 1598.35% in 2022.
  • Over the past 5 years, Jazz Pharmaceuticals' Assets Average (Quarter) stood at $12.4 billion in 2021, then fell by 14.36% to $10.6 billion in 2022, then increased by 6.49% to $11.3 billion in 2023, then rose by 7.39% to $12.1 billion in 2024, then fell by 8.11% to $11.2 billion in 2025.
  • Its last three reported values are $11.2 billion in Q3 2025, $11.2 billion for Q2 2025, and $11.8 billion during Q1 2025.